Multifunctional near infrared-emitting long-persistence luminescent nanoprobes for drug delivery and targeted tumor imaging

Biomaterials

Volumn 37, Issue , 2015, Pages 260-270

  Shi, Junpeng ^a   Sun, Xia ^a   Li, Jinlei ^a   Man, Huizi ^a   Shen, Jiangshan ^a   Yu, Yanke ^a   Zhang, Hongwu ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Drug delivery; Mesoporous; Persistent luminescence; Real time monitoring; Tumor targeting

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG PRODUCTS; INFRARED DEVICES; LUMINESCENCE; MESOPOROUS MATERIALS; NANOPROBES; SILICA; SURFACE TREATMENT; TUMORS;

DOXORUBICIN HYDROCHLORIDE; IN- SITU MONITORING; MESOPOROUS; MESOPOROUS SILICA; MESOPOROUS STRUCTURES; PERSISTENT LUMINESCENCE; REAL TIME MONITORING; TUMOR TARGETING;

TARGETED DRUG DELIVERY;

CHROMIUM; CHROMIUM DERIVATIVE; DOXORUBICIN; DRUG CARRIER; EUROPIUM; FOLATE RECEPTOR; FOLIC ACID; GALLIUM; GERMANIUM DERIVATIVE; MESOPOROUS SILICA NANOSPHERE; NANOPARTICLE; NANOSPHERE; NEAR INFRARED EMITTING LONG PERSISTENCE LUMINESCENT NANOPARTICLE; SILICA NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS ASSAY; ARTICLE; BIOCOMPATIBILITY; CANCER DIAGNOSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; DRUG MONITORING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT EMITTING DIODE; LUMINESCENCE; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SOLUBILITY; SUSTAINED DRUG RELEASE; SYNTHESIS; ANIMAL; CELL DEATH; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG EFFECTS; HEPG2 CELL LINE; INFRARED SPECTROSCOPY; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; PROCEDURES; SURFACE PROPERTY; ULTRASTRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL DEATH; DIAGNOSTIC IMAGING; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FOLIC ACID; HEP G2 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUMINESCENCE; MALE; MICE; NANOSPHERES; NEOPLASMS; POROSITY; SILICON DIOXIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTROSCOPY, NEAR-INFRARED; SURFACE PROPERTIES;

EID: 84922251266     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.10.033     Document Type: Article

References (36)

1. Yang P., Quan Z., Hou Z., Li C., Kang X., Cheng Z., et al. Amagnetic, luminescent and mesoporous core-shell structured composite material as drug carrier. Biomaterials 2009, 30:4786-4795.
2. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007, 46:7548-7558.
3. Slowing, Trewyn B.G., Giri S., Lin V.Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv Funct Mater 2007, 17:1225-1236.
4. 3+ for drug delivery. Microporous Mesoporous Mater 2013, 176:48-54.
5. Lei J., Wang L., Zhang J. Superbright multifluorescent core-shell mesoporous nanospheres as trackable transport carrier for drug. ACS Nano 2011, 5:3447-3455.
6. Qiu F., Wang D., Zhu Q., Zhu L., Tong G., Lu Y., et al. Real-time monitoring of anticancer drug release with highly fluorescent star-conjugated copolymer as a drug carrier. Biomacromolecules 2014, 15:1355-1364.
7. Yang P., Gai S., Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012, 41:3679-3698.
8. Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
9. He Q., Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. JMater Chem 2011, 21:5845-5855.
10. 3+@ hydrogel core-shell hybrid microspheres. ACS Nano 2012, 6:3327-3338.
11. Kim J., Lee J.E., Lee J., Yu J.H., Kim B.C., An K., et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. JAm Chem Soc 2006, 128:688-689.
12. Gai S., Yang P., Li C., Wang W., Dai Y., Niu N., et al. Synthesis of magnetic, up-conversion luminescent, and mesoporous core-shell-structured nanocomposites as drug carriers. Adv Funct Mater 2010, 20:1166-1172.
13. Resch-Genger U., Grabolle M., Cavaliere-Jaricot S., Nitschke R., Nann T. Quantum dots versus organic dyes as fluorescent labels. Nat Methods 2008, 5:763-775.
14. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum dots for live cells, invivo imaging, and diagnostics. Science 2005, 307:538-544.
15. Wang Z.L., Hao J., Chan H.L., Law G.L., Wong W.T., Wong K.L., et al. Simultaneous synthesis and functionalization of water-soluble up-conversion nanoparticles for in-vitro cell and nude mouse imaging. Nanoscale 2011, 3:2175-2181.
16. Chatterjee D.K., Rufaihah A.J., Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 2008, 29:937-943.
17. Maldiney T., Kaikkonen M.U., Seguin J., le Masne de Chermont Q., Bessodes M., Airenne K.J., et al. Invitro targeting of avidin-expressing glioma cells with biotinylated persistent luminescence nanoparticles. Bioconjug Chem 2012, 23:472-478.
18. Maldiney T., Richard C., Seguin J., Wattier N., Bessodes M., Scherman D. Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice. ACS Nano 2011, 5:854-862.
19. Li Z.J., Zhang H.W., Sun M., Shen J.S., Fu H.X. Afacile and effective method to prepare long-persistent phosphorescent nanospheres and its potential application for invivo imaging. JMater Chem 2012, 22:24713-24720.
20. Wu B.Y., Wang H.F., Chen J.T., Yan X.P. Fluorescence resonance energy transfer inhibition assay for α-fetoprotein excreted during cancer cell growth using functionalized persistent luminescence nanoparticles. JAm Chem Soc 2010, 133:686-688.
21. 8. Sci Rep 2013, 3.
22. Chermont QlM De, Chanéac C., Seguin J., Pellé F., Maîtrejean S., Jolivet J.P., et al. Nanoprobes with near-infrared persistent luminescence for invivo imaging. Proc Natl Acad Sci 2007, 104:9266-9271.
23. 3+ co-doped zinc gallogermanate persistent luminescent nanoparticles with superlong afterglow for invivo targeted bioimaging. JAm Chem Soc 2013, 135:14125-14133.
24. Maldiney T., Bessière A., Seguin J., Teston E., Sharma S.K., Viana B., et al. The invivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells. Nat Mater 2014, 13:418-426.
25. 4. Chem Mater 2013, 25:1600-1606.
26. Qiao Z.A., Zhang L., Guo M., Liu Y., Huo Q. Synthesis of mesoporous silica nanoparticles via controlled hydrolysis and condensation of silicon alkoxide. Chem Mater 2009, 21:3823-3829.
27. 2 nanocomposite fibers for anti-cancer drug delivery and cell imaging. Adv Funct Mater 2012, 22:2713-2722.
28. Geng J., Li K., Ding D., Zhang X., Qin W., Liu J., et al. Lipid-PEG-folate encapsulated nanoparticles with aggregation induced emission characteristics: cellular uptake mechanism and two-photon fluorescence imaging. Small 2012, 8:3655-3663.
29. Li K., Ding D., Huo D., Pu K.Y., Thao N.N.P., Hu Y., et al. Conjugated polymer based nanoparticles as dual-modal probes for targeted invivo fluorescence and magnetic resonance imaging. Adv Funct Mater 2012, 22:3107-3115.
30. 3+-doped zinc gallogermanates. Nat Mater 2012, 11:58-63.
31. Cheong W.F., Prahl S.A., Welch A.J. Areview of the optical properties of biological tissues. IEEE J Quantum Elect 1990, 26:2166-2185.
32. Mallik R., Wa C., Hage D.S. Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography. Anal Chem 2007, 79:1411-1424.
33. Xu Y., Jin X., Ping Q., Cheng J., Sun M., Cao F., et al. Anovel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. JControl Release 2010, 146:299-308.
34. Sudimack J., Lee R.J. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000, 41:147-162.
35. Luo Z., Hu Y., Cai K., Ding X., Zhang Q., Li M., et al. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity. Biomaterials 2014, 35:7951-7962.
36. Li X., He Q., Shi J. Global gene expression analysis of cellular death mechanisms induced by mesoporous silica nanoparticle-based drug delivery system. ACS Nano 2014, 8:1309-1320.